Focused Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8
| Closed | -$9 | – | 571 |
|
|
2023
Q4 | $9 | Hold |
8
| – | – | ﹤0.01% | 983 |
|
|
2023
Q3 | $9 | Hold |
8
| – | – | ﹤0.01% | 982 |
|
|
2023
Q2 | $11 | Hold |
8
| – | – | ﹤0.01% | 992 |
|
|
2023
Q1 | $12 | Hold |
8
| – | – | ﹤0.01% | 1001 |
|
|
2022
Q4 | $9 | Hold |
8
| – | – | ﹤0.01% | 1032 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 960 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 948 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 995 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 986 |
|
|
2021
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 972 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 904 |
|
|
2021
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 875 |
|
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 810 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 766 |
|
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 743 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 706 |
|
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 716 |
|
|
2019
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 711 |
|
|
2019
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 732 |
|
|
2019
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 701 |
|